Transformation of SV40-immortalized human uroepithelial cells by 3-methylcholanthrene increases IFN- and Large T Antigen-induced transcripts

Cancer Cell International

Volumn 10, Issue , 2010, Pages

  Crosby, Lynn M ^a,b,e   Moore, Tanya M ^a   George, Michael ^a   Yoon, Lawrence W ^c   Easton, Marilyn J ^c   Ni, Hong ^c   Morgan, Kevin T ^d   DeAngelo, Anthony B ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c GLAXOSMITHKLINE   (United States)

^d SANOFI   (France)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; 3 METHYLCHOLANTHRENE; ALPHA INTERFERON; GAMMA INTERFERON; INTERFERON; INTERFERON 56; INTERFERON INDUCIBLE PROTEIN [9-27]; MYXOVIRUS RESISTANCE PROTEIN A; MYXOVIRUS RESISTANCE PROTEIN AB; UNCLASSIFIED DRUG; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL FUNCTION; CELL GROWTH; CELL IMMORTALIZATION; CELL METABOLISM; CELL PROLIFERATION; CELL STRUCTURE; CELL TRANSFORMATION; CELL TYPE; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; DNA DAMAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INNATE IMMUNITY; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40; TUMOR GROWTH; UROEPITHELIAL CELL LINE; VIRUS CELL TRANSFORMATION;

EID: 77649330288     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-10-4     Document Type: Article

References (53)

1. Sweet BH, Hilleman MR. The vacuolating virus, S.V.40. Proc Soc Exp Med 1960, 105:420-427.
2. Jasani B, Cristaudo A, Emri SA, Gazdar AF, Gibbs A, Krynska B, Miller C, Mutti L, Radu C, Tognon M, et al. Association of SV40 with human tumours. Sem Cancer Biol 2001, 11:49-61.
3. Carbone M, Pass HI, Rizzo P, Marinetti M, Muzio MD, Mew DJY, Levine AS. The role of small t antigen in SV40 carcinogenesis. The Molecular Basis of Human Cancer 1991, 191-206. New York: Plenum Press, Nicolini C.
4. Cicala C, Pompetti F, Carbone M. SV40 induces mesotheliomas in hamsters. Am J Pathol 1993, 142:1524-1533. 1886912, 8388174.
5. Butel JS, Lednicky JA. Cell and Molecular Biology of Simian Virus 40: Implications for Human Infections and Disease. Journal of the National Cancer Institute 1999, 91:119-134. 10.1093/jnci/91.2.119, 9923853.
6. Rizzo P, Bocchetta M, Powers A, Foddis R, Stekala E, Pass HI, M MC. SV40 and the pathogenesis of mesothelioma. Seminars in Cancer Biology 2001, 11:63-71. 10.1006/scbi.2000.0347, 11243900.
7. Kean J, Rao S, Wang M, Garcea R. Seroepidemiology of human polyomaviruses. PLoS Pathog 2009, 5(3):e1000363. 10.1371/journal.ppat.1000363, 2655709, 19325891.
8. Imperiale MJ, Pass HI, Sanda MG. Prospects for an SV40 vaccine. Seminars in Cancer Biology 2001, 11:81-85. 10.1006/scbi.2000.0349, 11243902.
9. Rundell K, Parakati R. The role of SV40 ST antigen in cell growth promotion and transformation. Sem Cancer Biol 2001, 11:5-13.
10. Testa JR, Giordano A. SV40 and cell cycle perturbations in malignant mesothelioma. Sem Cancer Biol 2001, 11:31-38.
11. Pipas JM, Levine AJ. Role of T antigen interactions with p53 in tumorigenesis. Sem Cancer Biol 2001, 11:23-30.
12. Ali SH, DeCaprio JA. Cellular transformation by SV40 large T antigen: interaction with host proteins. Sem Cancer Biol 2001, 11:15-22.
13. Huschtscha LI, Neumann AA, Noble JR, Reddel RR. Effects of simian virus 40 T-antigens on normal human mammary epithelial cells reveal evidence for spontaneous alterations in addition to loss of p16(INK4a) expression. Exp Cell Res 2001, 265(1):125-134. 10.1006/excr.2001.5178, 11281650.
14. Sachsenmeier KF, Pipas JM. Inhibition of Rb and p53 is insufficient for SV40 T-antigen transformation. Virology 2001, 283(1):40-48. 10.1006/viro.2001.0866, 11312660.
15. Bocchetta M, Eliasz S, De Marco M, J R, L Z, Carbone M. The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth. Cancer Res 2008, 68(4):1022-1029. 10.1158/0008-5472.CAN-07-5203, 18281476.
16. O'Neill F. aCD: Amplification of papovavirus defectives during serial low multiplicity infections. Virology 1981, 112:800-803. 10.1016/0042-6822(81)90330-5, 6266155.
17. Carbone M, Pannuti A, Zhang L, Testa JR, Bocchetta M. A novel mechanism of late gene silencing drives SV40 transformation of human mesothelial cells. Cancer Res 2008, 68(22):9488-9496. 10.1158/0008-5472.CAN-08-2332, 2666620, 19010924.
18. Kroczynska B, Cutrone R, Bocchetta M, Yang H, Elmishad AG, Vacek P, Ramos-Nino M, Mossman BT, Pass HI, Carbone M. Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. Proceedings of the National Academy of Sciences USA 2006, 103(38):14128-14133.
19. Klaassen CD, . (ed) Casarett & Doull's Toxicology, The Basic Science of Poisons. 2001, New York: McGraw-Hill, 6, (ed).
20. Waring JF, Gum R, Morfitt D, Jolly RA, Ciurlionis R, Heindel M, Gallenberg L, Buratto B, Ulrich RG. Identifying toxic mechanisms using DNA microarrays: evidence that an experimental inhibitor of cell adhesion molecule expression signals through the aryl hydrocarbon nuclear receptor. Toxicology 2002, 181-182:537-550. 10.1016/S0300-483X(02)00477-8, 12505364.
21. Bartosiewicz MJ, Jenkins D, Penn S, Emery J, Buckpitt A. Unique Gene Expression Patterns in Liver and Kidney Associated with Exposure to Chemical Toxicants. Journal of Pharmacology and Experimental Therapeutics 2001, 297(3):895-905.
22. Waring JF, Jolly RA, Ciurlionis R, Lum PY, Praestgaard JT, Morfitt DC, Burratto B, Roberts C, Schadt E, Ulrich RG. Clustering of hepatotoxicants based on mechanism of toxicity using gene expression profiles. Toxicol Appl Pharmacol 2001, 175(1):28-42. 10.1006/taap.2001.9243, 11509024.
23. Waring JF, Ciurlionis R, Jolly RA, Heindel M, Ulrich RG. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol Lett 2001, 120(1-3):359-368. 10.1016/S0378-4274(01)00267-3, 11323195.
24. Reznikoff C, Loretz L, Christian B, Wu S, Meisner L. Neoplastic transformation of SV40-immortalized human urinary tract epithelial cells by in vitro exposure to 3-methylcholanthrene. Carcinogenesis 1988, 9:1427-1436. 10.1093/carcin/9.8.1427, 2841047.
25. Stark GR, Kerr IM, Williams BRG, Silverman RH, Schreiber RD. How Cells Respond to Interferons. Ann Rev Biochem 1998, 67:227-264. 10.1146/annurev.biochem.67.1.227, 9759489.
26. Technau A, Wolff A, Sauder C, Birkner N, Brandner G. p53 in SV40-transformed DNA-damaged human cells binds to its cognate sequence but fails to transactivate target genes. Int J Oncol 2001, 18(2):281-286.
27. Raghavan M. TAP-inhibitors from old world primate 1-herpesviruses and their use: WO2009008713. Expert Opin Ther Pat 20(2):277-282. 10.1517/13543770903501563, 20100007.
28. Christian BJ, Loretz LJ, Oberley TD, Reznikoff CA. Characterization of human uroepithelial cells immortalized in vitro by simian virus 40. Cancer Res 1987, 47(22):6066-6073.
29. Meisner LF, Wu SQ, Christian BJ, Reznikoff CA. Cytogenetic instability with balanced chromosome changes in an SV40 transformed human uroepithelial cell line. Cancer Res 1988, 48(11):3215-3220.
30. Kao C, Hauser P, Reznikoff WS, Reznikoff CA. Simian virus 40 (SV40) T-antigen mutations in tumorigenic transformation of SV40-immortalized human uroepithelial cells. J Virol 1993, 67(4):1987-1995. 240267, 8383222.
31. Kao C, Huang J, Wu SQ, Hauser P, Reznikoff CA. Role of SV40 T antigen binding to pRB and p53 in multistep transformation in vitro of human uroepithelial cells. Carcinogenesis 1993, 14(11):2297-2302. 10.1093/carcin/14.11.2297, 8242858.
32. Kao C, Wu SQ, DeVries S, Reznikoff WS, Waldman FM, Reznikoff CA. Carcinogen-induced amplification of SV40 DNA inserted at 9q12-21.1 associated with chromosome breakage, deletions, and translocations in human uroepithelial cell transformation in vitro. Genes Chromosomes Cancer 1993, 8(3):155-166. 10.1002/gcc.2870080304, 7509623.
33. Wu SQ, Christian BJ, Reznikoff CA, Meisner LF. Marker chromosome stability associated with neoplastic transformation of human uroepithelial cells. Cancer Genet Cytogenet 1988, 36(1):77-87. 10.1016/0165-4608(88)90077-5, 2849503.
34. Klingelhutz AJ, Wu SQ, Bookland EA, Reznikoff CA. Allelic 3p deletions in high-grade carcinomas after transformation in vitro of human uroepithelial cells. Genes Chromosomes Cancer 1991, 3(5):346-357. 10.1002/gcc.2870030505, 1686726.
35. Klingelhutz AJ, Wu SQ, Reznikoff CA. Nonrandom chromosome losses in tumorigenic revertants of hybrids between isogeneic immortal and neoplastic human uroepithelial cells. Somat Cell Mol Genet 1991, 17(6):551-565. 10.1007/BF01233620, 1767334.
36. Ikushima H, Miyazono K. Cellular context-dependent "colors" of transforming growth factor-beta signaling. Cancer Sci 2010, 101:306-312. 10.1111/j.1349-7006.2009.01441.x, 20067465.
37. Segal JG, Lee NC, Tsung YL, Norton JA, Tsung K. The role of IFN-gamma in rejection of established tumors by IL-12: source of production and target. Cancer Res 2002, 62(16):4696-4703.
38. Khorana AA, Rosenblatt JD, Sahasrabudhe DM, Evans T, Ladrigan M, Marquis D, Rosell K, Whiteside T, Phillippe S, Acres B, et al. A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma. Cancer Gene Ther 2003, 10(4):251-259. 10.1038/sj.cgt.7700568, 12679797.
39. Okamoto T, Tsuburaya A, Yanoma S, Yoshikawa T, Cho H, Takanashi Y, Noguchi Y. Inhibition of peritoneal metastasis in an animal gastric cancer model by interferon-gamma and interleukin-2. Anticancer Res 2003, 23(1A):149-153.
40. Panoskaltsis N, Reid CD, Knight SC. Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukaemia. Leukemia 2003, 17(4):716-730. 10.1038/sj.leu.2402835, 12682629.
41. Street SE, Cretney E, Smyth MJ. Perforin and interferon-gamma activities independently control tumor initiation, growth and metastasis. Blood 2001, 97(1):192-197. 10.1182/blood.V97.1.192, 11133760.
42. Reimer C, Queck I, Simon D, Kurth R, Baier M. Identification of Upregulated Genes in Scrapie-Infected Brain Tissue. Journal of Virology 2000, 74(21):10245-10248. 10.1128/JVI.74.21.10245-10248.2000, 102067, 11024157.
43. Nicholl MJ, Robinson LH, Preston CM. Activation of cellular interferon-responsive genes after infection of human cells with herpes simplex virus type 1. J Gen Virol 2000, 81(Pt 9):2215-2218.
44. Bonnevie-Nielsen V, Martensen PM, Justesen J, Kyvik KO, Kristensen B, Levin K, Beck-Nielsen H, Worsaa A, Dyrberg T. The antiviral 2',5'-oligoadenylate synthetase is persistently activated in type 1 diabetes. Clin Immunol 2000, 96(1):11-18. 10.1006/clim.2000.4874, 10873423.
45. Marschall M, Zach A, Hechtfischer A, Foerst G, Meier-Ewert H, Haller O. Inhibition of influenza C viruses by human MxA protein. Virus Res 2000, 67(2):179-188. 10.1016/S0168-1702(00)00140-4, 10867197.
46. Shizumu T, Kawakita S, Li QH, Fukuhara S, Fujisawa J. Human T-cell leukemia virus type 1 Tax protein stimulates the interferon-responsive enhancer element via NF-kappaB activity. FEBS Lett 2003, 539(1-3):73-77. 10.1016/S0014-5793(03)00200-X, 12650929.
47. Monier F, Surla A, Guillot M, Morel F. Gelatinase isoforms in urine from bladder cancer patients. Clinica Chimica Acta 2000, 299(1-2):11-23.
48. Bookland EA, Swaminathan S, Oyasu R, Gilchrist KW, Lindstrom M, Reznikoff CA. Tumorigenic transformation and neoplastic progression of human uroepithelial cells after exposure in vitro to 4-aminobiphenyl or its metabolites. Cancer Research 1992, 52:1606-1614.
49. Monier F, Surla A, Guillot M, Morel F. Gelatinase isoforms in urine from bladder cancer patients. Clin Chim Acta 2000, 299(1-2):11-23. 10.1016/S0009-8981(00)00271-0, 10900289.
50. Mook OR, Frederiks WM, Van Noorden CJ. The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 2004, 1705(2):69-89.
51. Bjorklund M, Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 2005, 1755(1):37-69.
52. Crosby LM, Morgan KT. Morphologic Analysis Correlates with Gene Expression in the F344 Rat Treated with Potassium Bromate. Toxicology and Applied Pathology 2000, 169:205-221.
53. Kepler TB, Crosby LM, Morgan KT. Normalization and analysis of DNA microarray data by self-consistency and local regression. Genome Biology 2002, 3(7):research0037.0031-0037.0012.